Despite recent advances in therapy, asthma continues to present an obstacle to many children. As pediatricians, we strive to provide the best management possible without preventing our patients from living a normal life. From the mildest attack of wheezing to the most severe life-threatening episode, we are called on to render the most effective management possible.
After reviewing this issue of Pediatric Annals, the practitioner should have a better understanding of IJ the mechanism of action and appropriate use of magnesium sulfate in the acute asthma attack, 2) the pathophysiology, primary précipitants, and management of exercise-induced bronchospasm, 3} the historical, physical, and laboratory markers of an acutely distressed asthmatic, and 4) the pathophysiology and evaluation of a chronic cough.
HOW TO OBTAIN CME CREDITS BY READING THIS ISSUE
Pediatricians can receive Category I credits for the Physician's Recognition Award of the American Medical Association by reading the following articles and successfully completing the quiz at the end of the issue. Complete instructions are given on the quiz pages.
The Pretest below has been prepared to assist you in studying the following material. It indicates some of the areas to be covered and will make it possible for you to challenge your present knowledge of the material before reading further.
1. Intravenous magnesium sulfate may be beneficial as a bronchodllator In the hospitalized asthmatic who Is refractory to standard therapy.
2. Airway Inflammation probably Is not a significant contributing factor In exerciseinduced bronchospasm.
3. As a result of advances In the treatment of asthma, the mortality rate from this disease Is declining.
4. A chronic cough Is defined as one that lasts for more than 3 weeks.
Answers to the Pretest:
1.A 2. A 3. B 4. A